STOCK TITAN

American Vanguard (AVD) Stock News

AVD NYSE

Welcome to our dedicated page for American Vanguard news (Ticker: AVD), a resource for investors and traders seeking the latest updates and insights on American Vanguard stock.

American Vanguard Corporation reports on its specialty agriculture and related product portfolio, including crop protection and management, turf and ornamentals management, public health, animal health and commercial pest control. The company develops, manufactures and markets synthetic, biological and biorational products, with a global registration base built through product and business acquisitions.

Recurring news for American Vanguard includes quarterly and annual earnings, product and margin commentary, manufacturing optimization, North American commercial execution, capital-structure actions and credit-facility updates. Company updates also discuss operating initiatives tied to working capital, debt reduction, manufacturing footprint and the organization of its crop and specialty businesses.

Rhea-AI Summary

American Vanguard (NYSE: AVD) reported positive financial results for the first quarter of 2024, with net sales reaching $135 million, Adjusted EBITDA up by 35% to $15.5 million, and Operating Income increasing by 87% to $6.1 million compared to the same period in 2023. Despite a slight decrease in net income and earnings per diluted share, the company's Chairman and CEO, Eric Wintemute, highlighted the improved operating leverage and cost control initiatives that contributed to the growth. The company also experienced growth in all three business segments, US Crop, US Non-crop, and International, with stable market conditions and increased sales across various product lines. However, the voluntary suspension of sales of the herbicide Dacthal due to concerns raised by USEPA led to adjustments in annual targets, setting a goal of 6% to 9% increase in net sales and an adjusted EBITDA target of $60 - $70 million for the year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.69%
Tags
-
Rhea-AI Summary

American Vanguard (NYSE: AVD) will report financial results for the first quarter on May 9, 2024. The conference call will focus on operating performance and financial results led by top executives. The company is a diversified specialty and agricultural products firm with a global presence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.86%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.37%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.81%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
dividends
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.61%
Tags
management
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.73%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.82%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.85%
Tags
dividends

FAQ

What is the current stock price of American Vanguard (AVD)?

The current stock price of American Vanguard (AVD) is $2.93 as of June 12, 2026.

What is the market cap of American Vanguard (AVD)?

The market cap of American Vanguard (AVD) is approximately 79.0M.